Your browser doesn't support javascript.
loading
[A CASE OF SEVERE ASTHMA RESULTING IN DISEASE EXACERBATION AFTER PROLONGATION OF THE DOSING INTERVAL AFTER LONG-TERM OMALIZUMAB ADMINISTRATION].
Matsumoto-Sasaki, Machiko; Shimizu, Kaoruko; Suzuki, Masanobu; Suzuki, Masaru; Kimura, Hirokazu; Nakamaru, Yuji; Konno, Satoshi.
Afiliación
  • Matsumoto-Sasaki M; Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University.
  • Shimizu K; Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University.
  • Suzuki M; Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University.
  • Suzuki M; Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University.
  • Kimura H; Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University.
  • Nakamaru Y; Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University.
  • Konno S; Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University.
Arerugi ; 71(8): 944-948, 2022.
Article en Ja | MEDLINE | ID: mdl-36089368
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Antiasmáticos Tipo de estudio: Guideline Límite: Humans Idioma: Ja Revista: Arerugi Año: 2022 Tipo del documento: Article Pais de publicación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Antiasmáticos Tipo de estudio: Guideline Límite: Humans Idioma: Ja Revista: Arerugi Año: 2022 Tipo del documento: Article Pais de publicación: Japón